SIETES :: 93213 citas

Resultados de la búsqueda por DERMATOLOGÍA REFINAR BÚSQUEDA

1.

Haugaard JH, Kofoed K, Gislason G, Dreyer L, Egeberg A. Association between drug use and subsequent diagnosis of lupus erythematosus. JAMA Dermatol 2020;156:2 de septiembre. [Ref.ID 103711]

2.

Kunchok A, Aksamit Jr AJ, Davis III JM, Kantarci OH, Keegan M, Pittock SJ, Weinshenker BG, McKeon A. Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. JAMA Neurology 2020;77:agosto. [Ref.ID 103656]

3.

Rai V. What is the evidence for the use of potassium permanganate for wound care?. Drug Ther Bull 2020;58:mayo. [Ref.ID 103653]

4.

Boulware DR, Pullen MF, Bangdiwala AS, Pastik KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, et al.. A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N Engl J Med 2020;383:3 de junio. [Ref.ID 103646]

5.

Esse S, Mason KJ, Green AC, Warren RB. Melanoma risk in patients treated with biologic therapy for common inflammatory diseases. A systematic review and meta-analysis. JAMA Dermatol 2020:20 de mayo. [Ref.ID 103629]

6.

Zhu H, Bateman BT, Gray KJ, Hernandez-Diaz S, Mogun H, Starub L, Huybrechts KF. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ 2020;369:20 de mayo. [Ref.ID 103628]

7.

Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. BMJ 2020;369:8 de abril. [Ref.ID 103595]

8.

Yang M-S, Lee JY, Kim J, Kim G-W, Kim B-K, Kim Y, Park H-W, Cho S-H, Min K-U, Kang H-R. Searching for the culprit drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis from a nationwide claim database in Korea. J Allergy Clin Immunol 2020;8:febrero. [Ref.ID 103535]

9.

Schuster BC, Brhlikova P, Heath J, McGettigan P. The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011–2018. PLOS Medicine 2019;16:10 de septiembre. [Ref.ID 103247]

10.

Marsh S. Suicides linked to acne drug Roaccutane as regulator reopens inquiry. The Guardian 2019:27 de diciembre. [Ref.ID 103237]

11.

Castells M, Khan DA, Phillips EJ. Penicillin allergy. N Engl J Med 2019;381:12 de diciembre. [Ref.ID 103229]

12.

Taylor P. BMS completes Celgene merger after FTC okay. PMLiVE 2019:18 de noviembre. [Ref.ID 103210]

13.

Azzouz B, Morel A, Kanagaratman L, Herlem E, Trenque T. Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 2019;42:diciembre. [Ref.ID 103209]

14.

Anónimo. Insect repellents. Med Lett Drugs Ther 2019;61:26 de agosto. [Ref.ID 103164]

15.

Andersen YMF, Egeberg A, Ban L, Gran S, Williams HC, Francis NA, Knop FK, Gislason GH, Skov L, Thyssen JP. Association between topical corticosteroid use and type 2 ciabetes in two European population-based adult cohorts. Diabetes Care 2019;42:junio. [Ref.ID 103163]

16.

Dommasch ED, Kim SC, Lee MP, Gagne JJ. Risk of serious infection in patients receiving systemic medications for the treatment of psoriasis. JAMA Dermatol 2019:10 de mayo. [Ref.ID 103131]

17.

Healy D. EMA acknowledges persistent sexual dysfunction after SSRIs & SNRIs. Rxisk 20019:11 de junio. [Ref.ID 103130]

18.

Anónimo. Ginkgo biloba: to be avoided due to severe adverse effects. Prescrire Int 2019;28:. [Ref.ID 103129]

19.

Matta MK, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Florian J, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong L-A, Ganley C, Michele T, Strauss DG. Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients. A randomized clinical trial. JAMA 2019:6 de mayo. [Ref.ID 103109]

20.

Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]